Consumer Goods » Food, Beverages & Tobacco | Rock Creek Pharmaceuticals Inc.

Rock Creek Pharmaceuticals Inc.

Rock Creek Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.77
Market Cap
$102.27 K
Shares Outstanding
170.45 M
Public Float
-

Profile

Address
2040 Whitfield Avenue
Sarasota Florida 34243
United States
Employees -
Website -
Updated 07/08/2019
Rock Creek Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for chronic inflammatory disease, neurologic disorders, and behavioral health utilizing its proprietary compounds. It focuses on pharmaceutical development activities centered primarily on anatabine citrate as a lead drug candidate. The company was founded by Jonnie R.

Financials

View All

Michael John Mullan
Chairman, President & Chief Executive Officer
Robert William Scannell
Independent Director